Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

CorMedix (CRMD) Return on Assets (2016 - 2025)

Historic Return on Assets for CorMedix (CRMD) over the last 12 years, with Q3 2025 value amounting to 0.32%.

  • CorMedix's Return on Assets rose 9300.0% to 0.32% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.32%, marking a year-over-year increase of 9300.0%. This contributed to the annual value of 0.45% for FY2022, which is 200.0% up from last year.
  • Latest data reveals that CorMedix reported Return on Assets of 0.32% as of Q3 2025, which was up 9300.0% from 0.25% recorded in Q2 2025.
  • Over the past 5 years, CorMedix's Return on Assets peaked at 0.32% during Q3 2025, and registered a low of 0.79% during Q2 2024.
  • In the last 5 years, CorMedix's Return on Assets had a median value of 0.43% in 2022 and averaged 0.35%.
  • In the last 5 years, CorMedix's Return on Assets crashed by -1700bps in 2022 and then soared by 10400bps in 2025.
  • CorMedix's Return on Assets (Quarter) stood at 0.39% in 2021, then decreased by -22bps to 0.48% in 2022, then dropped by -12bps to 0.54% in 2023, then soared by 66bps to 0.18% in 2024, then soared by 277bps to 0.32% in 2025.
  • Its Return on Assets stands at 0.32% for Q3 2025, versus 0.25% for Q2 2025 and 0.13% for Q1 2025.